The landscape of diabetes treatment is rapidly evolving, and cellular treatment are emerging as a remarkably intriguing area of study. While conventional treatments often focus on managing blood glucose levels and addressing complications, regenerative therapy holds the potential to target the underlying origins of Adult-Onset diabetes. Researchers